Cogent Biosciences Stock 346% Surge Fueled by New Stake
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
This article explains the balance between strong cryptography and practical attack vectors, illustrating why no system is perfectly immune to breaches.
28,220 articlesA Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Celebrity moments can shape our choices—sometimes inspiring smart budgeting, other times fueling impulse buys. This a...
Palantir is moving beyond a services banner toward a durable AI-first platform. If the company scales its AI plumbing...
Investing in rare earths is a long game tied to U.S. policy, global demand, and the pace of production. This guide co...
A high-stakes legal clash between Archer Aviation and Joby could swing how investors price the whole eVTOL space. Her...
Energy markets move fast, but a 10-year horizon changes the game. This guide helps you identify what best energy stoc...
Meta is weighing a large primary equity offering to fund an aggressive AI buildout as costs rise. Analysts warn dilut...
Credit card networks operate with enormous reach and reliable revenue streams. This article explains the business mod...
Micron's strategy will face a sweeping test as two giants in the memory market push forward with enormous spending. T...
Sam Altman raised questions about SpaceX's bold plan for AI data centers in space. This article breaks down the viabi...
Dividend-focused investors know that a reliable yield can cushion markets. This guide explores an ultra-high-yield co...
Can Netflix grow from its current scale to a trillion-dollar market value? This article breaks down the unlikely path...